The game changer' heart failure treatment that cuts deaths by two thirdsA new treatment for heart failure significantly reduces deaths and hospital readmissions, marking a breakthrough in patient care.
British hospitals introduce treatment for heart failure that cuts deaths by 62%New treatment approach for heart failure patients dramatically reduces mortality and hospital readmissions.
Sweden's Acorai bags 4.2M to advance heart failure management devicesAcorai secures $4.5M funding for its heart failure management device and aims for market launch by 2026.
Dublin-based FIRE1 secures 115M to help patients suffering from chronic diseases - Silicon CanalsFIRE1 secured $120M to advance heart failure management technology through clinical trials and FDA recognition.
The game changer' heart failure treatment that cuts deaths by two thirdsA new treatment for heart failure significantly reduces deaths and hospital readmissions, marking a breakthrough in patient care.
British hospitals introduce treatment for heart failure that cuts deaths by 62%New treatment approach for heart failure patients dramatically reduces mortality and hospital readmissions.
Sweden's Acorai bags 4.2M to advance heart failure management devicesAcorai secures $4.5M funding for its heart failure management device and aims for market launch by 2026.
Dublin-based FIRE1 secures 115M to help patients suffering from chronic diseases - Silicon CanalsFIRE1 secured $120M to advance heart failure management technology through clinical trials and FDA recognition.
Australian man survives 100 days with artificial heart in world-first successA man in Australia became the first in the world to walk out of a hospital with a total artificial heart implant.
London heart attack patient, 71, is Britain's first to get lifesaving chemotherapy-style' treatmentA pioneering heart attack treatment could reduce deaths by nearly two-thirds and improve patients' quality of life.
How a Brooklyn hospital network is addressing disparities in the outer boroughsMaimonides Medical Center addresses healthcare disparities by providing advanced heart failure treatment with L.V.A.D., enhancing patient quality of life in Brooklyn.
Australian man survives 100 days with artificial heart in world-first successA man in Australia became the first in the world to walk out of a hospital with a total artificial heart implant.
London heart attack patient, 71, is Britain's first to get lifesaving chemotherapy-style' treatmentA pioneering heart attack treatment could reduce deaths by nearly two-thirds and improve patients' quality of life.
How a Brooklyn hospital network is addressing disparities in the outer boroughsMaimonides Medical Center addresses healthcare disparities by providing advanced heart failure treatment with L.V.A.D., enhancing patient quality of life in Brooklyn.
Kevin Campbell died of natural causes - inquestKevin Campbell died of natural causes related to heart and kidney failure, as concluded by a coroner.
Woman Becomes First Person to Receive Both Pig Kidney Transplant and Heart PumpA groundbreaking procedure involving a genetically modified pig kidney transplant offers hope for patients with both heart and kidney disease.
Kevin Campbell died of natural causes - inquestKevin Campbell died of natural causes related to heart and kidney failure, as concluded by a coroner.
Woman Becomes First Person to Receive Both Pig Kidney Transplant and Heart PumpA groundbreaking procedure involving a genetically modified pig kidney transplant offers hope for patients with both heart and kidney disease.
An artificial heart may save your life. But it can also change you in surprising waysAn Australian man became the first patient to leave the hospital with an artificial heart while waiting for a transplant.
Breakthrough Titanium Heart Design Successfully Implanted in a Human - Yanko DesignThe BiVACOR Total Artificial Heart (TAH) offers a groundbreaking solution for severe heart conditions, suitable for patients ineligible for traditional devices.
An artificial heart may save your life. But it can also change you in surprising waysAn Australian man became the first patient to leave the hospital with an artificial heart while waiting for a transplant.
Breakthrough Titanium Heart Design Successfully Implanted in a Human - Yanko DesignThe BiVACOR Total Artificial Heart (TAH) offers a groundbreaking solution for severe heart conditions, suitable for patients ineligible for traditional devices.
Shared Pathways in HIV and Aging May Contribute to Heart Failure Risk - News CenterA unique protein signature linked to HIV may highlight new therapeutic targets for heart failure.
Scientists trial patch to mend failing heartsLab-grown heart muscle patches may provide new treatment for advanced heart failure.Early results indicate safety and potential for heart repair using these muscle patches.
Groundbreaking': scientists develop patch that can repair damaged heartsResearchers have developed implantable patches to treat heart failure using laboratory-grown heart muscle, offering new hope for patients.The patches made from reprogrammed blood cells are a breakthrough in biological transplants for heart conditions.
Scientists trial patch to mend failing heartsLab-grown heart muscle patches may provide new treatment for advanced heart failure.Early results indicate safety and potential for heart repair using these muscle patches.
Groundbreaking': scientists develop patch that can repair damaged heartsResearchers have developed implantable patches to treat heart failure using laboratory-grown heart muscle, offering new hope for patients.The patches made from reprogrammed blood cells are a breakthrough in biological transplants for heart conditions.
Weight-loss drug reduces risk of early death for patients with heart failure, trial findsTirzepatide reduces the risk of death and worsening heart failure in patients with obesity and preserved heart function.
Semaglutide leads to greater weight loss in women than men with HF and improves HF symptomsSemaglutide improves heart failure symptoms, with sex-based differences in weight loss and benefits.
Weight-loss drug reduces risk of early death for patients with heart failure, trial findsTirzepatide reduces the risk of death and worsening heart failure in patients with obesity and preserved heart function.
Semaglutide leads to greater weight loss in women than men with HF and improves HF symptomsSemaglutide improves heart failure symptoms, with sex-based differences in weight loss and benefits.